Risk of thromboembolism after acute cardioversion of atrial fibrillation

Lancet

Volumn 352, Issue 9136, 1998, Pages 1280-

  Omran, H ^a   Jung, W ^b   Luderitz B ^b  

^a UNIVERSITY OF BONN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT THERAPY; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; RISK; SINUS RHYTHM; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0032541847     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70486-4     Document Type: Article

References (4)

1. 1 Jung W, Lüderitz B. Implantable atrial defibrillator - quo vadis? PACE 1997; 20: 100-09.
2. 2 Omran H, Jung W, Rabahieh R, et al. Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study. J Am Coll Cardiol 1997; 29: 131-38.
3. 3 Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994; 23: 307-16.
4. 4 Grimm RA, Stewart WJ, Maloney JD, et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography, J Am Coll Cardiol 1993; 22: 1359-66.